Skip to main content
. 2021 Feb 25;4(2):479–487. doi: 10.1021/acsptsci.0c00189

Table 2. Summary of the Potency (EC50) and Efficacy (Emax, Where the Emax of Either Serotonin or LSD is Set to 100%) Values of All the Tested Compounds in the miniGαq Recruitment Assay, Calculated Using Either the Full 120 Min or the First 30 Min Activation Profilesa.

120 min activation profiles
  reference agonist LSD
reference agonist serotonin
compound EC50 (nM, CI) Emax (%, CI) EC50 (nM, CI) Emax (%, CI)
LSD 7.40 (1.82–17.7) 100 (84–115) 7.23 (1.73–17.5) 39.6 (33.7–46.0)
serotonin 66.4 (35.5–151) 256 (230–301) 63.5 (33.9–143) 103 (92.5–121)
23H-NBOMe 147 (71.8–436) 81.2 (70–102) 146 (73.8–408) 31.9 (27.5–39.6)
24H-NBOMe 22.1 (12.1–42.1) 144 (129–161) 22.2 (12.4–41.6) 56.9 (51.2–63.4)
25H-NBOMe 49.6 (27.2–84.8) 141 (128–155) 49.2 (26.6–85.4) 58.8 (53.3–64.9)
26H-NBOMe 40.9 (23.7–68.2) 136 (124–148) 40.9 (23.9–67.7) 53.3 (48.8–58.2)
34H-NBOMe 974 (ND) 134 (ND) 947 (ND) 55.3 (45.6–297)
35H-NBOMe 1097 (ND) 89.1 (74–219) 1087 (ND) 37.1 (30.5–112)
30 min activation profiles
  reference agonist LSD
reference agonist serotonin
compound EC50 (nM, CI) Emax (%, CI) EC50 (nM, CI) Emax (%, CI)
LSD 17.7 (10.1–38.6) 98.2 (85–114) 16.3 (8.59–38.7) 31.9 (27.4–37.2)
serotonin 88.5 (46.1–213) 305 (272–365) 62.2 (22.5–269) 87.9 (74.4–121)
23H-NBOMe 236 (ND) 89.6 (75–112) 191 (ND) 27.1 (22.6–33.3)
24H-NBOMe 37.4 (20.6–66.4) 171 (155–189) 35.1 (17.5–68.7) 54.3 (48.5–61.2)
25H-NBOMe 86.2 (57.0–124) 181 (167–196) 129 (69.2–263) 74.8 (65.6–88.8)
26H-NBOMe 68.0 (38.6–115) 162 (147–181) 68.3 (34.0–129) 51.9 (46.0–59.4)
34H-NBOMe 1321 (629–33 780) 156 (130–340) 1334 (ND) 51.8 (ND)
35H-NBOMe 1393 (ND) 107 (94–163) 1296 (683–10 760) 48.3 (41.0–83.6)
a

Data are from three independent experiments. CI: 95% confidence interval. ND: confidence interval not determined.